SAMSRITA fair value: what the stock is really worth
As of Oct 1, 2026: fair value of SAMSRITA ₹2.44, price ₹11.76, upside -79.3%, quality 34 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch SAMSRITA for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 27, 2026.
How to read this chart
60‑month range ₹10.60 – ₹42.05 · fair‑value band ₹1.82 – ₹3.65 · the ₹11.76 price screens above the ₹2.44 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 27, 2026.
Follow SAMSRITA in your weekly email
Every Wednesday you see whether SAMSRITA is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
SAMSRITA (SAMSRITA) currently trades at ₹11.76, while our model-based Fair Value estimate is ₹2.44, 79.3% below the price, so the stock looks overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 1 models at a data quality of 96/100, which puts the evidence level at low.
Scenario range: ₹1.82 (bear) to ₹3.65 (bull), the price of ₹11.76 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 34/100 (below-average quality), in the Health Care sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
SAMSRITA reported revenue of ₹181K in FY2026 versus ₹225K in FY2022, a compound −5.2%/yr. Reported net income was −₹81.6M in FY2026.
Key figures
Market cap ₹268M (≈ $2.8M) · EPS (TTM) ₹−3.99 · Return on equity −68.8% · Return on assets (EBIT) −13.6% · Operating margin −239% · Revenue (TTM) ₹181K · Free cash flow −₹50.2M · Net debt ₹332K.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 22 out of 100 (low confidence).
What moves the price
The share trades about 52% below its 52-week high and 11% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Health Care peers we cover trades at −46% fair-value upside, at −79%, SAMSRITA screens richer than that median.
Fair Value models
Bear ₹1.82Fair Value ₹2.44Bull ₹3.65
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.15/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−5.8%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.9%
Start year 2021 (pandemic)
’21
’22
’23
’26
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−7,051.9% (2021) → −48,163.0% (2026)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2026 is a loss year, no rate is defined from a loss
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its sector: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median. (Industry “Health Care Services” was too small, so the broader sector is used.)Health Care · 2412 stocks
Beats the sector median on 0/5 measures
Overall it trails its sector peers.
Valuation
Quality Score37 · Bottom 25%
Fair Value upside−75.6% · Bottom 25%
Profitability
Return on assets−36.4% · Bottom 25%
Growth and dividend
Revenue growth0.0% · Below median
Valuation Multiplesvs Health Care median · lower = cheaper
P/S (TTM)15.35× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 7
FUTURE (revenue growth)0· sector 26
PAST (return on equity)0· sector 14
HEALTH (low debt)100· sector 96
DIVIDEND (yield)0· sector 33
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "SAMSRITA Fair Value". https://www.fairvalue-calculator.com/stock/SAMSRITA
Frequently asked questions
Is SAMSRITA overvalued or undervalued?
As of Sep 27, 2026, our model estimates a fair value of ₹2.44 versus a price of ₹11.76, about −79% upside (overvalued).
What is the fair value of SAMSRITA?
Our model-based fair value for SAMSRITA is ₹2.44 (as of Sep 27, 2026), built from audited fundamentals. The current price: ₹11.76.
What is the quality score of SAMSRITA?
SAMSRITA has a Quality Score of 34/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for SAMSRITA?
Our model-based price target is the fair value of ₹2.44 (as of Sep 27, 2026) from 1 valuation models. Cautious scenario ₹1.82, optimistic scenario ₹3.65. It is a calculation from audited fundamentals, not an analyst target.
What is the SAMSRITA stock forecast for 2026?
Our models put fair value at ₹2.44, about −79% upside versus a price of ₹11.76 (overvalued). Cautious scenario ₹1.82, optimistic scenario ₹3.65. The calculation is refreshed regularly with new filings.
What is the revenue of SAMSRITA?
SAMSRITA reported trailing-twelve-month revenue of about ₹181K (latest available figure, as of Sep 27, 2026).
What is the intrinsic value of SAMSRITA?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For SAMSRITA it is ₹2.44 per share (as of Sep 27, 2026), against a price of ₹11.76. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is SAMSRITA stock overvalued or undervalued in 2026?
As of Sep 27, 2026, SAMSRITA trades above its calculated fair value: price ₹11.76, fair value ₹2.44, a gap of about −79% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of SAMSRITA?
No. The price is what the market pays today (₹11.76); the fair value is what the company's own numbers justify (₹2.44). For SAMSRITA the two are ₹9.32 per share apart. That gap is exactly why we show both numbers side by side.
How much is SAMSRITA worth?
The market values SAMSRITA at about ₹268M (market capitalisation, as of Sep 27, 2026). Per share that is ₹11.76; our models calculate a fair value of ₹2.44 per share.
What do the bullish and bearish scenarios say about SAMSRITA?
Our models span a range for SAMSRITA: cautious scenario ₹1.82, base ₹2.44, optimistic ₹3.65 per share (as of Sep 27, 2026, price ₹11.76). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of SAMSRITA?
Balance-sheet figures for SAMSRITA (as of Sep 27, 2026): return on equity −68.8%. They feed the Quality Score of 34/100, which measures business quality independently of the share price.
How far is SAMSRITA from its 52-week high?
SAMSRITA trades at ₹11.76, about 52% below its 52-week high of ₹24.31 and 11% above the low of ₹10.60 (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of ₹2.44 is for.
Which stocks are comparable to SAMSRITA?
From the same area (Health Care) we also value LOOKS, PINC, KMCSHIL, SHUKRAPHAR, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is SAMSRITA stock attractive at the current price?
The data as of Sep 27, 2026: price ₹11.76, calculated fair value ₹2.44 (−79%), Quality Score 34/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of SAMSRITA calculated?
We run SAMSRITA through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹2.44, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. SAMSRITA itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of SAMSRITA?
The closing price on Oct 1, 2026 was ₹11.76. Our model-based fair value is ₹2.44, about −79% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with SAMSRITA right now?
The price sits above even our optimistic bull case (₹3.65). The favourable scenario is already priced in. Weak quality (34/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range (₹1.82 to ₹3.65) leaves room in how you read the outcome.
Key figures of SAMSRITA
How large is the market capitalisation of SAMSRITA?
The market capitalisation of SAMSRITA is ₹268M (≈ $2.8M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What are the earnings per share of SAMSRITA?
Earnings per share at SAMSRITA are ₹−3.99. Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of SAMSRITA?
The return on equity (ROE) of SAMSRITA is −68.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of SAMSRITA?
On an EBIT basis the return on assets of SAMSRITA is −13.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of SAMSRITA?
The operating margin of SAMSRITA is −239% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How much free cash flow does SAMSRITA generate?
The free cash flow of SAMSRITA is −₹50.2M (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does SAMSRITA carry?
The net debt of SAMSRITA is ₹332K (fiscal year 2026). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch SAMSRITA in the live analysis
One click puts SAMSRITA on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
